Tuesday 13 October 2026 Export CLX’s income statement to Excel — free account

The Clorox Company

CLX Consumer Defensive Household & Personal Products

The Clorox Company’s revenue for fiscal 2026 (year ended June 2026) was $6.7 billion, down 5.41% from fiscal 2025. In the quarter to June 2026, revenue fell 2.01%, EPS fell 50.4%, free cash flow grew 11.4% and total debt rose 60.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years; insiders bought in the last twelve months.

84.35 0.55 +0.66%

Follow CLX

Alert me

Market cap: $10.2B
P/E: 17.5×
Fwd P/E: 14.8×
Dividend yield: 7.37%
F-score: 4/9
Altman Z: 2.10
Beneish M: −2.43
Dividend safety: 26/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Insider Decisions trades per month

Total buys 0.85

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	1	—	—	—	—	—	1	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 1.41%

Capital & Financial Ratios $m

Market Cap 10,200.00

Revenue 6,720.00

Net Income 601.00

Free Cash Flow 405.00

Net Debt 3,839.00

Current Ratio 0.66

Debt/Equity 15.80

P/E ratio 17.50

Fwd P/E 14.80

P/S ratio 1.53

P/B ratio 40.76

Past 5Y EPS Growth (2.93%)

This Y EPS Growth 3.84%

Next Y EPS Growth 7.87%

Next Y revenue growth 13.54%

Next 5Y EPS Growth 5.41%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 4.95%

10-year low 10-year high

P/S against its own 10 years 0.55%

10-year low 10-year high

P/B against its own 10 years 57.00%

10-year low 10-year high

EV/Sales against its own 10 years 2.44%

10-year low 10-year high

EV/FCF against its own 10 years 84.98%

10-year low 10-year high

Dividends

Payout Ratio 1.29

Annual Dividend Rate 6.22

Annual Dividend Yield 7.37%

	total	individual payouts
2029	Powerpack
2028	Powerpack
2027	Powerpack
2026	4.98	1.24 1.24 1.25 1.25
2025	4.92	1.22 1.22 1.24 1.24
2024	4.84	1.20 1.20 1.22 1.22
2023	4.76	1.18 1.18 1.20 1.20
2022	4.68	1.16 1.16 1.18 1.18
2021	4.54	1.11 1.11 1.16 1.16
2020	4.34	1.06 1.06 1.11 1.11
2019	4.04	0.96 0.96 1.06 1.06
2018	3.72	0.84 0.96 0.96 0.96
2017	3.28	0.80 0.80 0.84 0.84
2016	3.14	0.77 0.77 0.80 0.80

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	2026
Cash	367	202	167	143
Receivables	688	695	821	791
Inventory	696	637	523	777
Other	—	—	—	—
	1,828	1,622	1,608	1,824

	2023	2024	2025	2026
Payables	1,659	1,486	1,828	1,600
ST’ Debt	146	—	—	1
Other	—	—	—	—
	1,917	1,574	1,919	2,773

Compound Annual Growth %

	10y	5y	3y
Sales	1.55%	(1.75%)	(3.11%)
Cash Flow	(2.37%)	(13.67%)	(19.15%)
Earnings	(0.98%)	(3.73%)	57.94%
Book Value	(1.63%)	(15.70%)	(13.40%)

Revenue $m

	Sep	Dec	Mar	Jun	Year
’26	—	—	—	—	—
’26	1,429	1,673	1,670	1,948	6,720
’25	1,762	1,686	1,668	1,988	7,104
’24	1,386	1,990	1,814	1,903	7,093
’23	1,740	1,715	1,915	2,019	7,389
’22	1,806	1,691	1,809	1,801	7,107
’21	1,916	1,842	1,781	1,802	7,341

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Sep	Dec	Mar	Jun	Year
’26	—	—	—	—	—
’26	93	311	(122)	330	612
’25	221	180	286	294	981
’24	20	153	182	340	695
’23	178	209	341	430	1,158
’22	41	181	229	335	786
’21	383	246	264	383	1,276

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Sep	Dec	Mar	Jun	Year
’26	—	—	—	—	—
’26	57	269	(165)	244	405
’25	182	127	233	219	761
’24	(4)	101	127	259	483
’23	132	167	285	346	930
’22	(11)	124	166	256	535
’21	314	164	183	284	945

Fiscal quarters ending in the months shown.

EPS $

	Sep	Dec	Mar	Jun	Year
’26	—	—	—	—	—
’26	0.65	1.29	1.54	1.34	4.81
’25	0.80	1.54	1.50	2.68	6.52
’24	0.17	0.75	(0.41)	1.73	2.25
’23	0.68	0.80	(1.71)	1.42	1.20
’22	1.14	0.56	1.21	0.81	3.73
’21	3.22	2.03	(0.49)	0.78	5.58

Fiscal quarters ending in the months shown.

Group	Line	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026	2027e
Price, $
Price, $	Low	118.41	113.57	143.58	150.95	156.23	120.50	114.69	127.60	96.66	79.12	Analyst estimates 2027–2029 Powerpack
	High	150.40	167.70	166.90	239.87	231.11	186.86	178.21	171.37	164.22	128.90
People
People	Employees	8,100	8,700	8,800	8,800	9,000	9,000	8,700	8,000	7,600	9,200
	Revenue/emp, $m	0.74	0.70	0.71	0.76	0.82	0.79	0.85	0.89	0.93	0.73
Income, $m
Income, $m	Revenue	5,973	6,124	6,214	6,721	7,341	7,107	7,389	7,093	7,104	6,720
	Gross margin, %	44.72	43.68	43.90	45.57	43.58	35.81	39.36	42.97	45.23	42.32
	EBT	1,033	1,054	1,024	1,185	900	607	238	398	1,078	791
	EBT margin, %	17.29	17.21	16.48	17.63	12.26	8.54	3.22	5.61	15.17	11.77
	Net income	701	823	820	939	719	471	161	292	824	601
	Depreciation	163	166	180	180	540	224	681	235	219	247
Per share, $
Per share, $	Revenue	46.32	47.37	48.65	53.41	58.46	57.73	59.79	57.12	57.51	55.18
	Earnings	5.43	6.37	6.42	7.46	5.66	3.75	1.21	2.26	6.56	4.82
	Cash flow	6.71	7.55	7.77	12.29	10.16	6.38	9.37	5.60	7.94	5.03
	Capex	(1.79)	(1.50)	(1.61)	(2.02)	(2.64)	(2.04)	(1.84)	(1.71)	(1.78)	(1.70)
	Free cash flow	4.92	6.05	6.15	10.27	7.53	4.35	7.52	3.89	6.16	3.33
	Book value	4.20	5.62	4.38	7.22	4.71	5.92	3.14	3.96	3.90	2.07
	Shares, m	129	129	128	126	126	123	124	124	124	122
Valuation, ×
Valuation, ×	P/E	24.49	20.93	23.73	29.41	31.90	37.70	130.36	59.66	18.30	19.80
	P/S	2.88	2.82	3.14	4.11	3.08	2.44	2.66	2.35	2.09	1.73
	P/B	31.70	23.78	34.92	30.40	38.16	23.81	50.66	33.88	30.77	46.12
	EV/Sales	3.11	3.24	3.56	4.40	3.41	2.81	2.97	2.73	2.48	2.30
	EV/FCF	29.27	25.34	28.11	22.89	26.51	37.32	23.56	40.13	23.11	38.18
Cash, $m
Cash, $m	Operating cash flow	865	976	992	1,546	1,276	786	1,158	695	981	612
	Capex	(231)	(194)	(206)	(254)	(331)	(251)	(228)	(212)	(220)	(207)
	Free cash flow	634	782	786	1,292	945	535	930	483	761	405
Balance, $m
Balance, $m	Working capital	(295)	111	(135)	602	(227)	(59)	(89)	48	(311)	(949)
	Total debt	1,791	2,483	2,683	2,846	2,784	2,795	2,623	2,481	2,484	3,982
	Net debt	1,373	2,352	2,572	1,975	2,465	2,612	2,256	2,279	2,317	3,839
	Shareholders’ equity	542	726	559	908	592	729	388	492	482	252
Returns, %
Returns, %	ROA	15.44	17.09	16.12	16.58	11.32	7.40	2.46	4.79	14.32	8.79
	ROIC	36.78	23.07	22.44	27.62	18.95	14.03	9.64	11.55	24.12	13.95
	ROE	167.10	129.81	127.63	128.02	94.67	69.95	26.68	63.64	166.32	159.95

Negative figures in brackets.

All 10 years →

Fiscal years to Jun 2026 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
EL The Estee Lauder Companies Inc.	$35.5B	196×	28.0×	+6.33% (above 0%: growing)	n/m	+7.87% (above 0%: growing)	75.46%	(1.08%)	Compare
KVUE Kenvue Inc.	$34.0B	20.5×	18.6×	+3.02% (above 0%: growing)	+9.09% (above 0%: growing)	+17.07% (above 0%: growing)	58.18%	17.67%	Compare
KMB Kimberly-Clark Corporation	$32.5B	16.8×	14.4×	+0.62% (above 0%: growing)	−32.03% (below 0%: shrinking)	−4.79% (below 0%: shrinking)	38.27%	15.11%	Compare
CHD Church & Dwight Co., Inc.	$23.3B	32.0×	26.3×	+1.57% (above 0%: growing)	+10.26% (above 0%: growing)	+23.33% (above 0%: growing)	45.35%	18.07%	Compare
CLX The Clorox Company	$10.1B	17.5×	14.8×	−2.01% (below 0%: shrinking)	−50.37% (below 0%: shrinking)	+11.42% (above 0%: growing)	41.27%	13.24%
ELF e.l.f. Beauty	$6.5B	110×	21.2×	+35.52% (above 0%: growing)	+91.53% (above 0%: growing)	+447.39% (above 0%: growing)	83.20%	21.37%	Compare
IPAR Interparfums, Inc.	$3.6B	21.5×	18.8×	+2.13% (above 0%: growing)	−5.00% (below 0%: shrinking)	+1,031.52% (above 0%: growing)	65.54%	14.35%	Compare
COTY Coty	$2.5B	— (loss-making)	11.8×	+1.34% (above 0%: growing)	n/m	+20.86% (above 0%: growing)	60.88%	(3.36%)	Compare
NWL Newell Brands Inc.	$2.4B	— (loss-making)	7.4×	+3.05% (above 0%: growing)	+127.27% (above 0%: growing)	+84.62% (above 0%: growing)	40.72%	14.19%	Compare
Median of peers	$14.9B	26.7×	18.7×	+2.58%	+9.68%	+22.10%	59.53%	14.73%

All 32 Household & Personal Products stocks →

The Clorox Company (CLX) key facts

Concern: The Clorox Company’s revenue for fiscal 2026 (year ended June 2026) was $6.7 billion, down 5.41% from fiscal 2025.
Concern: Net income was $601.0 million, or $4.82 per share (basic), a net margin of 8.74%.
The Clorox Company (CLX) is a Household & Personal Products company in the Consumer Defensive sector, listed on the New York Stock Exchange.
As of October 12, 2026, CLX traded at $84.35, a market capitalization of $10.2 billion.
At that price the stock trades at 17.5× trailing-twelve-month earnings and 1.5× sales; its P/E is higher than 5% of its own readings over the past ten years.
The Clorox Company pays an annual dividend of $6.22 per share, a yield of 7.37%, with a payout ratio of 129.1%.
Return on equity was 160.0% and debt-to-equity 15.80.
Its Piotroski F-score is 4 out of 9 and its Altman Z-score is 2.10 (grey zone) for fiscal 2026.